D216-0314 Screening compound: 4-(3-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}benzenesulfonyl)morpholine

D216-0314 Screening compound: 4-(3-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}benzenesulfonyl)morpholine
D216-0314 Screening compound: 4-(3-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}benzenesulfonyl)morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound D216-0314
4-(3-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}benzenesulfonyl)morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D216-0314

Molecular Formula

C18H23N5O5S2 (C18 H23 N5 O5 S2)

Compound Name

4-(3-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}benzenesulfonyl)morpholine

IUPAC name

4-(3-{[4-(pyrimidin-2-yl)piperazin-1-yl]sulfonyl}benzenesulfonyl)morpholine

SMILES

O=S(c1cccc(S(N2CCOCC2)(=O)=O)c1)(N(CC1)CCN1c1ncccn1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.54

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.339

Distribution Coefficient, logD

1.339

Water Solubility, LogSw

-2.23

Polar Surface Area

93.191

Acid Dissociation Constant (pKa)

20.87

Base Dissociation Constant (pKb)

3.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.40

D216-0314 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Autophagy-Targeted Library (4564 compounds)

CNS MPO Library (28609 compounds)

Dark Chemical Matter Library (18430 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Akt-Targeted Library (14764 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Pool
Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Others
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with D216-0314 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D216-0314?
Check Price and Availability of D216-0314, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D216-0314 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D216-0314
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D216-0314
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D216-0314 available by request